跳至主要内容
临床试验/NL-OMON53519
NL-OMON53519招募中不适用

FAPi-PET imaging of in vivo fibrosis in inflammatory bowel disease patients - PIMAFI

Amsterdam UMC0 个研究点目标入组 20 人开始时间: 待定最近更新:
适应症

试验速览

阶段
不适用
状态
招募中
发起方
入组人数
20

研究概览

简要总结

暂无简介。

研究设计

研究类型
Observational

入排标准

年龄范围
18 至 99(—)

入选标准

  • Group 1 - Adults >=18 years with confirmed diagnosis of Crohn*s disease AND one
  • of the following: - Gastrointestinal complaints such as diarrhea, bloody and/
  • or lose stools and abdominal pain, or obstructive symptoms. - Increased CRP (>5
  • mg/L) and/or fecal calprotectin levels (>250 mg/kg) - Active disease confiremed
  • by endoscopy ( endoscopic SES-CD score >3) - Active disease confirmed by IUS or
  • MRI (bowel wall thickening, signs of active disease) Group 2 - Adults >=18 years
  • with confirmed diagnosis of ulcerative colitis AND one of the following: -
  • Active disease confirmed by endoscopy (endoscopic Mayo score >= 2) or - Active
  • disease confirmed by intestinal ultrasound (BWT > 3 mm in atleast one bowel
  • segment and atleast one other pathological IUS parameter) - Increased CRP (>5
  • mg/L) and/or fecal calprotectin levels (>250 mg/kg)

排除标准

  • - Pregnancy
  • - Unable to provide informed consent
  • - IBD-related surgeries less than 5 years ago in medical history
  • - Colorectal cancer

研究者

发起方
Amsterdam UMC

相似试验